People with diabetes and obesity are at higher risk for severe respiratory illness caused by viruses, including serious ...
More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...
U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...
An Ahmedabad boy, aged four, has tested positive for human metapneumovirus, raising Gujarat's total cases to eight. The child ...
Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit ...
As new viruses like COVID-19, bird flu, norovirus, and RSV (respiratory syncytial virus) continue to spread, vaccines have ...
WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- COVID-19 continues to be a threat to America’s health, causing more illness and ...
With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...
The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...